Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

358 ARTÍCULOS , VIENDO DEL 136 AL 150

A proposed preventive role for Gamma-hydroxybutyrate (Xyrem(R)) in Alzheimer's disease

Maitre M, Klein C, Mensah-Nyagan AG.

Alzheimers Res Ther. 2016 Sep 6;8(1):37. doi: 10.1186/s13195-016-0205-y.

Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease

Devassy JG, Leng S, Gabbs M, Monirujjaman M, Aukema HM.

Adv Nutr. 2016 Sep 15;7(5):905-16. doi: 10.3945/an.116.012187. Print 2016 Sep.

Recent Findings in Alzheimer Disease and Nutrition Focusing on Epigenetics

Athanasopoulos D, Karagiannis G, Tsolaki M.

Adv Nutr. 2016 Sep 15;7(5):917-27. doi: 10.3945/an.116.012229. Print 2016 Sep.

Drug development in Alzheimer's disease: the path to 2025

Cummings J, Aisen PS, DuBois B, Frölich L, Jack CR Jr, Jones RW, Morris JC, Raskin J, Dowsett SA, Scheltens P.

Alzheimers Res Ther. 2016 Sep 20;8:39. doi: 10.1186/s13195-016-0207-9.

Spices: Potential Therapeutics for Alzheimer's Disease

Satheeshkumar N, Vijayan RS, Lingesh A, Santhikumar S, Vishnuvardhan Ch.

Adv Neurobiol. 2016;12:57-78. doi: 10.1007/978-3-319-28383-8_4.

Alzheimer's Disease and Medicinal Plants: An Overview

Manoharan S, Essa MM, Vinoth A, Kowsalya R, Manimaran A, Selvasundaram R.

Adv Neurobiol. 2016;12:95-105. doi: 10.1007/978-3-319-28383-8_6.

Potential of the Antibody Against cis-Phosphorylated Tau in the Early Diagnosis, Treatment, and Prevention of Alzheimer Disease and Brain Injury

Lu KP, Kondo A, Albayram O, Herbert MK, Liu H, Zhou XZ.

JAMA Neurol. 2016 Nov 1;73(11):1356-1362. doi: 10.1001/jamaneurol.2016.2027.

Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients

Panza F, Seripa D, Solfrizzi V, Imbimbo BP, Lozupone M, Leo A, Sardone R, Gagliardi G, Lofano L, Creanza BC, Bisceglia P, Daniele A, Bellomo A, Greco A, Logroscino G.

Expert Opin Emerg Drugs. 2016 Dec;21(4):377-391. doi: 10.1080/14728214.2016.1241232. Epub 2016 Oct 6.

An Update on Biomedical Application of Nanotechnology for Alzheimer's Disease Diagnosis and Therapy

Panahi Y, Mohammadhosseini M, Abadi AJ, Akbarzadeh A, Mellatyar H.

Drug Res (Stuttg). 2016 Nov;66(11):580-586. doi: 10.1055/s-0042-112811. Epub 2016 Oct 4.

New Age Therapy for Alzheimer's Disease by Neuronal Network Reconstruction

Tohda C.

Biol Pharm Bull. 2016;39(10):1569-1575. doi: 10.1248/bpb.b16-00438.

Therapeutic strategies for the treatment of tauopathies: Hopes and challenges

Khanna MR, Kovalevich J, Lee VM, Trojanowski JQ, Brunden KR.

Alzheimers Dement. 2016 Oct;12(10):1051-1065. doi: 10.1016/j.jalz.2016.06.006.

Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer's Disease Immunotherapy

Liu J, Yang B, Ke J, Li W, Suen WC.

Drugs Aging. 2016 Oct;33(10):685-697. doi: 10.1007/s40266-016-0406-x.

Cathepsin D as a therapeutic target in Alzheimer's disease

Di Domenico F, Tramutola A, Perluigi M.

Expert Opin Ther Targets. 2016 Dec;20(12):1393-1395. doi: 10.1080/14728222.2016.1252334. Epub 2016 Nov 2.

Alzheimer's disease: cerebrolysin and nanotechnology as a therapeutic strategy

Sharma HS, Muresanu DF, Sharma A.

Neurodegener Dis Manag. 2016 Dec;6(6):453-456. doi: 10.2217/nmt-2016-0037. Epub 2016 Nov 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias